Publications

Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis.

Hauser SL, Bar-Or A, Weber MS, Kletzl H, G?nther A, Manfrini M, Model F, Mercier F, Petry C, Wing Q, Koendgen H, Smith T, Kappos L

2023
Plastin 3 rescues BDNF-TrkB signaling in spinal muscular atrophy.

Ramsey A, Huang EJ

2023
Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology.

de Majo M, Koontz M, Marsan E, Salinas N, Ramsey A, Kuo YM, Seo K, Li H, Dr?ger N, Leng K, Gonzales SL, Kurnellas M, Miyaoka Y, Klim JR, Kampmann M, Ward ME, Huang EJ, Ullian EM

2023
Prdm16 and Vcam1 regulate the postnatal disappearance of embryonic radial glia and the ending of cortical neurogenesis.

Li J, Godoy MI, Zhang AJ, Diamante G, Ahn IS, Cebrian-Silla A, Alvarez-Buylla A, Yang X, Novitch BG, Zhang Y

2023
Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains.

Rheinberger M, Costa AL, Kampmann M, Glavas D, Shytaj IL, Sreeram S, Penzo C, Tibroni N, Garcia-Mesa Y, Leskov K, Fackler OT, Vlahovicek K, Karn J, Lucic B, Herrmann C, Lusic M

2023
Cerebellar deep brain stimulation for the treatment of movement disorders in cerebral palsy.

Cajigas I, Morrison MA, Luciano MS, Starr PA

2023
Epileptiform discharges triggered with direct electrical stimulation for treatment-resistant depression: Factors that modulate risk and treatment considerations.

Fan JM, Khambhati AN, Sellers KK, Stapper N, Maya DA, Kunwar E, Henderson C, Sugrue LP, Scangos KW, Chang EF, Rao VR, Krystal AD

2023
Characterization of De Novo Promoter Variants in Autism Spectrum Disorder with Massively Parallel Reporter Assays.

Koesterich J, An JY, Inoue F, Sohota A, Ahituv N, Sanders SJ, Kreimer A

2023
Conserved gene signatures shared among MAPT mutations reveal defects in calcium signaling.

Minaya MA, Mahali S, Iyer AK, Eteleeb AM, Martinez R, Huang G, Budde J, Temple S, Nana AL, Seeley WW, Spina S, Grinberg LT, Harari O, Karch CM

2023
MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state.

You SF, Brase L, Filipello F, Iyer AK, Del-Aguila J, He J, D'Oliveira Albanus R, Budde J, Norton J, Gentsch J, Dr?ger NM, Sattler SM, Kampmann M, Piccio L, Morris JC, Perrin RJ, McDade E, Dominantly Inherited Alzheimer Network, Paul SM, Cashikar AG, Benitez BA, Harari O, Karch CM

2023

Pages